GSTP1 and posterior cortical atrophy: A multicentre study has validated the use of three gene panel (GSTP1, APC and RARβ2) as a diagnostic maker for PCa [122–125], and moreover several approaches have shown the potential use of PTGS CpG island hyper-methylation as an important tool for recurrence risk prediction [126].